KRYS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Krystal Biotech Inc

Watchlist Manager

Watchlist

Price: 332.425 USD 1.64% Market Closed

Market Cap: $9.8B

	Krystal Biotech Inc NASDAQ:KRYS	US
U	Uber Technologies Inc F:UT8	US
	Gold Fields Ltd F:EDG	ZA
A	Alpha Services and Holdings SA SWB:ACBB	GR
C	China Shenhua Energy Co Ltd SWB:IKF	CN
	Subsea 7 SA F:SOC	UK
F	Fabrinet XBER:FAN	KY
	Ping An Insurance Group Co of China Ltd F:PZXB	CN

Profitability Summary

Krystal Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

94%

Exceptional Operating Margin

45%

Negative 3Y Average Operating Margin

-126%

Exceptional Net Margin

55%

Sustainable 3Y Average Net Margin

12%

Exceptional Free Cash Flow Margin

59%

Negative 3Y Average Free Cash Flow Margin

-108%

Positive ROE

20%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

ROIC is Increasing

-76% > 38%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.